NJK14047
Chemical compound
NJK14047 | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
NJK14047 is a chemical compound that has been studied for its potential therapeutic effects, particularly in the context of neurodegenerative diseases. It is known for its role as a modulator of neurotrophic factors, which are crucial for the survival, development, and function of neurons.
Chemical Structure[edit | edit source]
NJK14047 is characterized by its complex molecular structure, which includes a piperazine ring and a trifluoromethyl group. The presence of these functional groups is significant for its biological activity, influencing its interaction with various biological targets.
Mechanism of Action[edit | edit source]
NJK14047 functions primarily by modulating the activity of neurotrophic factors. These factors, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), play a pivotal role in neuronal health. By influencing these pathways, NJK14047 may help in promoting neuronal survival and regeneration, which is particularly beneficial in conditions like Alzheimer's disease and Parkinson's disease.
Potential Therapeutic Applications[edit | edit source]
The primary interest in NJK14047 lies in its potential application in treating neurodegenerative disorders. By enhancing the activity of neurotrophic factors, NJK14047 could potentially slow down or reverse the progression of diseases characterized by neuronal loss. Research is ongoing to determine its efficacy and safety in clinical settings.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of NJK14047 is still under investigation. Understanding its absorption, distribution, metabolism, and excretion (ADME) is crucial for developing it as a therapeutic agent. Preliminary studies suggest that it has a favorable profile, but more research is needed to confirm these findings.
Safety and Efficacy[edit | edit source]
As with any potential therapeutic compound, the safety and efficacy of NJK14047 must be thoroughly evaluated through clinical trials. Initial studies have shown promise, but comprehensive trials are necessary to establish its therapeutic value and safety profile.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD